Poor glycaemic control and high blood pressure are two important risk factors for the development of retinopathy and nephropathy in Type 1 diabetes. The renin-angiotensin-aldosterone system (RAAS) may be involved in this process, since treatment with angiotensin-converting enzyme (ACE) inhibitors postpones the development of these complications. We investigated whether plasma renin activity (PRA), plasma angiotensin II (Ang II) and atrial natriuretic peptide (ANP) differed in Type 1 diabetic patients compared with healthy controls. We recruited 80 patients with Type 1 diabetes of more than 10 years' duration and 75 age-matched controls. We found that PRA and Ang II concentrations were significantly lower in patients than in the controls. The levels of ANP, on the other hand, were higher in patients than in controls. PRA correlated negatively to the mean value of HbA 1c during the previous five years. PRA and Ang II were significantly lower in patients with mean HbA 1c >8.4% compared with those with mean HbA 1c <7.2%. In summary, we found patients with Type 1 diabetes to have RAAS suppression and increased ANP levels, suggesting a state of fluid retention.
Introduction
Poor glycaemic control and high blood pressure are risk factors for nephropathy in Type 1 diabetes. The renin-angiotensin-aldosterone system (RAAS) may be involved in this process since treatment with angiotensin-converting enzyme (ACE) inhibitors has been shown to retard the progress of albuminuria. 1, 2 However, if this effect of ACE-inhibitors depends specifically upon inhibition of the RAAS, or if it is caused mainly by blood pressure reduction, has not been clarified. 3 Indeed, it has not been clearly settled whether concentrations of the circulating components of the RAAS are increased, 4 normal, 5, 6 or decreased 7, 8 in subjects with Type 1 diabetes. In particular, the long-term effects of glycaemic control on the circulating components of the RAAS are not clear. At best, a single value of glycosylated haemoglobin (HbA 1c ) has been obtained and correlated to the activity of the RAAS. 6, 9 The levels of atrial natriuretic peptide (ANP) also affect fluid homeostasis. Cardiac atrial distension causes release of ANP, which allows loss of sodium and fluid in the kidney, thus normalising the plasma volume. 10 In order to assess the activity level of the RAAS in Type 1 diabetes, we undertook an investigation of the levels of plasma renin activity (PRA), plasma angiotensin II (Ang II) and ANP in 80 patients with different levels of long-term glycaemic control and urinary-albumin excretion rates (u-AER).The levels of these markers of the RAAS were related to those obtained from 75 age-matched control subjects.
Methods

Patients and protocol
We studied 80 patients with onset of Type 1 diabetes before the age of 15 years and a duration of diabetes of more than 10 years. Seventy-five agematched control subjects were selected from the population as previously described. 11 None of the patients or controls were on antihypertensive treatment.
The patients were admitted to our metabolic ward after an overnight fast.Weight was recorded after voiding of urine. Blood pressure was measured in the right arm after 5 minutes' rest in the supine position and after 2 minutes in the standing position, using a mercury manometer with an appropriately adjusted cuff width. Systolic blood pressure was recorded as Korotkoff phase I and diastolic blood pressure as phase V, respectively. Blood samples for determination of PRA, Ang II and ANP were drawn from the antecubital vein after the subject had been sitting for at least 5 minutes.
Measurement of HbA 1c was performed several times a year in the patients, usually every three to four months. The subjects were grouped according to level of glycaemic control (mean value of all HbA 1c during the years 1986 to 1991: 'Good' <7.2%, n=51,'Poor' 7.2-8.4%, n=20 and 'Very Poor' > 8.4%, n=9). The cut-off levels for this classification have previously been evaluated in a prospective study. 12 Micro-albuminuria was defined as u-AER between 30-300 mg in at least two out of three consecutive 24-hour urine collections. Macro-albuminuria was defined as an u-AER of >300 mg/24 hours.
Ethics
The study was approved by the Ethics Committee of the Medical Faculty at the University of Linköping, Sweden, and performed in accordance with the Declaration of Helsinki. sured by RIA. Total coefficients (intra-and interassay) of variation for PRA, Ang II and ANP were <12%, <12% and 11%, respectively. HbA 1c was analysed by high-performance liquid chromatography (HPLC:Auto A1c HA 8810, Kyoto Daichi, Kyoto, Japan) for which the reference range was 3.2-6.0%.
Statistical analyses
Results are given as mean ± SD or median and ranges. Statistical analyses were performed with the unpaired or paired Students' two-tailed t-test for comparisons within or between groups. Pearson's test was generally used in regression analyses, the exception being in correlations where u-AER was a variable, in which Spearman's rank test was used due to the skewed distribution of albuminuria. We used 75 control subjects for the 80 patients, and so five of the control subjects were used twice in the paired comparisons. The p-values for the paired comparisons were also identical when the analyses were done in only 75 pairs, avoiding double usage of five of the controls.
Results
Patients and controls were successfully matched for gender and age, as seen in Table 1 .
The patients had lower PRA ( Figure 1 ) and Ang II levels than controls (p<0.001 for both), whilst ANP was higher in the diabetics than in the control subjects (p<0.0001, Table 1 ).
PRA and Ang II were significantly lower in the patients with 'Very Poor' long-term glycaemic control compared with those with 'Good' control, as seen in Table 2 .The slight differences in the levels of ANP between these groups did not reach statistical significance.
In the patients, PRA correlated weakly and negatively with the mean value of HbA 1c over the prior five years of investigation (r=-0.29, p=0.01, see also Figure 2 ) but not with the single value of HbA 1c on the day of examination (r=-0.13, p=0.25). No correlations were found between Ang II or ANP and the level of glycaemic control.
Eleven patients had micro-albuminuria and four were macro-albuminuric. However, there was no relationship between u-AER and any of the studied components of the RAAS. The difference in the levels of PRA in normo-albuminuric patients as compared with controls was statistically significant (p=0.003).
There was no correlation between either systolic or diastolic blood pressure and RAAS components in the patients.
Discussion
We found suppressed levels of both PRA and Ang II in Type 1 diabetic patients as compared with agematched control subjects. Similar results have previously been reported in smaller studies. 6, 9, 16 Levels of PRA are known to be negatively correlated with age in the population. 11 However, the difference in PRA between patients and controls was not an age-related phenomenon, since the controls were successfully matched for age.
PRA correlated more strongly with mean HbA 1c over a five-year period,than with a single HbA 1c measurement on the day of examination. This suggests that PRA is affected by the long-term effect of hyperglycaemia. Furthermore, it is in accordance with the fact that it is the long-term effect of hyperglycaemia, and not a single value of HbA 1c , that is well correlated to nephropathy and retinopathy.The 15 patients that were albuminuric,on the other hand,did not differ with respect to the RAAS components, from the other patients. The normo-albuminuric patients exhibited a suppressed PRA, compared with controls.This suggests that the mechanisms responsible for suppression of the RAAS come in to play before albuminuria develops. Another possibility would be a direct effect of hyperglycaemia per se on the activity of the RAAS. Previous studies on this topic have yielded somewhat contradictory results. Miller et al. subjected eleven males with Type 1 diabetes to hyperglycaemia for 12 hours and reported an increase in the levels of PRA. 17 On the other hand, in a study by Stenvinkel et al., an intravenous injection of 5% glucose to healthy subjects induced a suppression of PRA as well as a 40% decrease in fractional sodium excretion, 18 results that have been confirmed by others. 19 In the population, levels of PRA and Ang II are strongly related. 11 However, we found that, in the diabetics, PRA, but not Ang II, correlated negatively to HbA 1c . The determination of the levels of PRA are dependent on liver-produced angiotensinogen. It is possible that the particularly low PRA in subjects with high HbA 1c was caused by low liver-production of angiotensinogen as a consequence of diabetesrelated changes in liver function. Such a mechanism has been reported by Correa-Rotter et al. in rats. 20 PRA was found to be significantly lower in hyperglycaemic diabetic rats compared with non-diabetic controls, although renal renin mRNA was not different between the two groups. Furthermore, renal and liver angiotensinogen mRNA were lower in the diabetic rats as compared with controls. 20 The suppressed RAAS observed in the patients suggests fluid-retention. Consistent with this, we found higher levels of ANP in the diabetic subjects than in the controls.This confirms the result of a previous report in a mixed population of Type 1 and 2 diabetics. 9 In summary, this study firmly establishes that adult subjects with Type 1 diabetes exhibit clear signs of fluid retention, as reflected by a suppressed RAAS and an increase in ANP, when compared with age-matched controls. These findings are independent of age, blood pressure or the degree of nephropathy. 
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